{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P53396",
      "entity_text" : "ACLY",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0568" ],
      "Cellular_component" : [ "go:GO:0005829" ],
      "Organ" : [ "uberon:UBERON:0000105" ]
    }
  },
  "verbose_text" : "Distinctive elevation of ACLY expression and activity has been reported in lung, ovarian, prostate, bladder, breast, liver, stomach, and colon cancers [XREF_BIBR - XREF_BIBR], and its inhibition by siRNAs or the selective inhibitor SB-204990 suppresses the growth and survival of tumor cells in vitro and in vivo [XREF_BIBR].",
  "reading_complete" : "2020-08-02T15:32:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:30:26Z",
  "trigger" : "expression",
  "evidence" : [ "ACLY expression" ],
  "pmc_id" : "4359538",
  "score" : 0
}